Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 406

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 406
---
 |     | 24/04/2014  |     |        14/786,652 |     | 20/03/2018 |     |  9,920,297 |     |   14/786,652 |     | 24/04/2034 |     | granted |
| US      |     | CON  |     | 24/04/2014  |     |        15/872,750 |     | 27/10/2020 |     | 10,815,455 |     | 2018/0163169 |     | 24/04/2034 |     | granted |

VXM04-MSLN (4)
WO 2015/090584, Novel MSLN targeting DNA vaccine for cancer immunotherapy

| Country 
 Code    |     | Type |     | Filing date |     |        Filing no. |     | Grant Date |     |  Grant no. |     |    Publ. No. |     | Expiry     |     | Status  |
| WO      |     | PCT  |     | 17/12/2014  |     | PCT/EP2014/003403 |     |            |     |            |     |  2015/090584 |     | —          |     |         |
| EP*     |     | PCT  |     | 17/12/2014  |     |      14 821 508.0 |     | 28/08/2019 |     |  3 082 850 |     |    3 082 850 |     | 17/12/2034 |     | granted |
| JP      |     | PCT  |     | 17/12/2014  |     |       2016-559513 |     | 14/01/2020 |     |    6662787 |     |  2017-502692 |     | 17/12/2034 |     | granted |
| US      |     | CON  |     | 17/12/2014  |     |        15/785,743 |     | 15/10/2019 |     | 10,441,645 |     | 2018/0064794 |     | 17/12/2034 |     | granted |

VXM01